Levoflox 500 mg IV Infusion 100 ml is a sterile intravenous antibiotic solution containing FDA-approved Levofloxacin (500 mg) as its active ingredient. Cipla Ltd manufactures Levoflox Infusion in GMP-compliant facilities.
It is used in the treatment of moderate to severe bacterial infections, including kin and soft tissue infections, Pneumonia, complicated Urinary Tract Infections (UTIs), and chronic bacterial Prostatitis. The infusion should be stored between 15°C and 25°C, protected from light, and must not be frozen or used if the solution shows discoloration or particulate matter.
Its active ingredient, Levofloxacin, belongs to the fluoroquinolone class of antibiotics. It works by inhibiting two essential bacterial enzymes, DNA gyrase and Topoisomerase IV, both of which are required for bacterial DNA replication, transcription, repair, and recombination.
By blocking these enzymes, Levofloxacin causes irreversible damage to bacterial DNA, halting bacterial replication and leading rapidly to bacterial cell death. This bactericidal mechanism is effective against a broad spectrum of gram-positive and gram-negative organisms, including atypical pathogens such as Mycoplasma, Chlamydophila, and Legionella.
The intravenous route is used when oral therapy is not feasible or when the severity of the infection requires rapid, predictable medication delivery. Levoflox 500 Infusion is typically administered once daily over a minimum of 60 minutes, as directed by a prescribing physician in a hospital or clinical setting.
Some of its common side effects include nausea, diarrhea, headache, dizziness, and injection site reactions. Levofloxacin carries a risk of Tendinitis and tendon rupture, particularly in older patients, those on corticosteroids, and organ transplant recipients.
Inform a doctor immediately if tendon pain, weakness, or neurological symptoms develop during therapy. Before administering Levoflox 500 Infusion, inform a doctor of any history of tendon disorders, seizures, Myasthenia Gravis (a chronic neuromuscular disease that weakens muscles), kidney disease, or known hypersensitivity to fluoroquinolone antibiotics.
Levoflox 500 Infusion provides targeted antibacterial benefits for patients with serious infections requiring intravenous therapy. Some of them include:
Levoflox 500 mg Infusion is a prescription medication for hospital or clinical use only and must be administered strictly by or under the supervision of a qualified healthcare professional. General administration considerations include:
Levoflox is available in different strengths and types at Cheap Medicine Shop, whether for oral or injectable therapy. You can consider the following effective options:
| Levoflox 750 Mg IV Infusion | $8.75/injection |
| Levoflox 500 mg | $3.50/10 tablets |
Like any medication, Levoflox 500 Infusion may cause some side effects. Most are mild and resolve as the body adjusts to the medicine. Some of them include:
Always consult a medical professional if any of these effects persist or worsen. Moreover, some side effects, such as tendon rupture and peripheral neuropathy (damage to the nerves outside the brain and spinal cord), are serious and require immediate medical attention.
Liver Disease
Individuals with liver disease should use Levoflox 500 Infusion with caution. While Levofloxacin is primarily excreted through the kidneys rather than the liver, severe liver disease may require dose adjustment. Inform a doctor of any liver conditions before initiating intravenous therapy.
Kidney Impairment
Levofloxacin 500 Infusion requires dose adjustment in patients with kidney disease, as Levofloxacin is predominantly eliminated through the kidneys. Reduced clearance leads to medicine accumulation and an increased risk of toxicity, including central nervous system effects and tendon damage. Kidney function must be assessed before and during therapy, and the dose should be adjusted according to creatinine clearance under medical supervision.
Pregnant and Breastfeeding women
Levofloxacin is not recommended during pregnancy. Animal studies have shown adverse effects on fetal development. The medicine also passes into breast milk and is not recommended during breastfeeding, as its effects on the nursing infant have not been established. Consult a doctor immediately if treatment is considered necessary in these circumstances.
Avoid
Do not use Levoflox 500 Infusion in patients with known hypersensitivity to Levofloxacin or any fluoroquinolone antibiotic. It is contraindicated in patients with a history of tendon disorders, especially related to fluoroquinolone use or Myasthenia Gravis. Avoid use with antacids or iron supplements, which can interfere with absorption if transitioning to oral therapy. Do not expose the patient to excessive sunlight or UV radiation during treatment, as Levofloxacin increases photosensitivity. Inform a doctor of all current medications before administration.
Yes, Levoflox 500 mg IV Infusion contains Levofloxacin, a broad-spectrum fluoroquinolone antibiotic. It works by inhibiting bacterial DNA replication enzymes, leading to bacterial cell death. It is effective against a variety of gram-positive, gram-negative, and atypical organisms responsible for serious infections.
Yes, Levoflox 500 Infusion is specifically used for moderate to severe bacterial infections where intravenous delivery is required. Its broad-spectrum bactericidal activity and near-complete bioavailability via the IV route make it effective for serious infections, including hospital-acquired Pneumonia, complicated UTIs, and skin and soft tissue infections.
Inform a doctor of any history of tendon disorders, seizures, Myasthenia Gravis, QT prolongation, or fluoroquinolone hypersensitivity before starting therapy. Kidney function must be assessed, as dose adjustment is required in renal impairment. Avoid concurrent QT-prolonging medications and exposure to excessive sunlight during the course of treatment.
Yes, Levofloxacin is associated with Tendinitis (inflammation of tendons) and tendon rupture, most commonly affecting the Achilles tendon. The risk is higher in elderly patients, those on corticosteroids, and organ transplant recipients. Stop the infusion and inform a doctor immediately if tendon pain, swelling, or difficulty moving a joint develops.
Levoflox 500 Infusion must be used with caution and dose adjustment in people with kidney disease. Since Levofloxacin is primarily excreted through the kidneys, impaired function significantly reduces its clearance and increases the risk of toxicity. Kidney function should be assessed before and monitored throughout intravenous therapy.
The duration of treatment depends on the type and severity of the infection. It typically ranges from 5 days for uncomplicated UTIs to up to 14 days for Pneumonia or skin infections. A doctor will determine the appropriate course length based on clinical response, culture results, and overall condition.
Yes, once a patient shows clinical improvement on intravenous therapy, a doctor can transition to an equivalent oral dose of Levofloxacin. This is a common and well-supported practice, as oral Levofloxacin has high bioavailability and maintains comparable blood levels to the intravenous formulation, often allowing earlier hospital discharge.